Clinical Trials · NCT01602913
Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- GlaxoSmithKline
- Enrollment
- 1
- Start date
- Dec 2011
- Locations
- See registry
- Primary endpoint
- Incidence of T2DM defined as having at least 2 diagnostic codes indicating T2DM after the index date, or 1 diagnostic code and 1 prescription of oral anti-diabetic medications or insulin (or Byetta and Victoza) after the index date